Evidence map›Paper›PMID 38928057›Full record

ArticleInternational journal of molecular sciences2024

Genetic Profiling of Sebaceous Carcinoma Arising from an Ovarian Mature Teratoma: A Case Report.

Sumika Zaitsu, Yoko Aoyagi, Haruto Nishida, Kohei Nakamura, Mitsutake Yano, Eiji Kobayashi

Abstract readCase Reports
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sumika ZaitsuDepartment of Obstetrics and Gynecology, Faculty of Medicine, Oita University, Oita 879-5593, Japan.
Yoko AoyagiDepartment of Obstetrics and Gynecology, Faculty of Medicine, Oita University, Oita 879-5593, Japan.
Haruto NishidaDepartment of Diagnostic Pathology, Faculty of Medicine, Oita University, Oita 879-5593, Japan.ORCID 0000-0003-2959-8002
Kohei NakamuraGenomics Unit, Keio Cancer Center, School of Medicine, Keio University, Tokyo 160-8582, Japan.ORCID 0000-0002-5162-7132
Mitsutake YanoDepartment of Obstetrics and Gynecology, Faculty of Medicine, Oita University, Oita 879-5593, Japan.ORCID 0000-0002-4436-838X
Eiji KobayashiDepartment of Obstetrics and Gynecology, Faculty of Medicine, Oita University, Oita 879-5593, Japan.

Funding

Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology 22K15409
6 · The paper itself

Abstract

Ovarian mature teratomas (OMTs) originate from post-meiotic germ cells. Malignant transformation occurs in approximately 1-2% of OMTs; however, sebaceous carcinoma arising from OMTs is rare. This is the first report of a detailed genomic analysis of sebaceous carcinoma arising from an OMT. A 36-year-old woman underwent evaluation for abdominal tumors and subsequent hysterectomy and salpingo-oophorectomy. Pathologically, a diagnosis of stage IA sebaceous carcinoma arising from an OMT was established. Eight months post-surgery, the patient was alive without recurrence. Immunohistochemically, the tumor was negative for mismatch repair proteins. A nonsense mutation in

Indexed as

Ovarian NeoplasmsTeratomaTumor Suppressor Protein p53Adenocarcinoma, SebaceousAdultCell Transformation, NeoplasticClass Ia Phosphatidylinositol 3-KinaseFemaleHumansPolymorphism, Single NucleotideClass Ia Phosphatidylinositol 3-KinasePIK3R1 protein, humanTP53 protein, humanTumor Suppressor Protein p53malignant transformation: endoreduplicationovarian teratomaPIK3R1sebaceous carcinomaTP53uniparental disomy

Identifiers

PMID38928057
PMCPMC11203495

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.